Last updated: 2026-10-16 19:53:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
HeartSciences Inc. (HSCS) operates in the FINANCE SERVICES sector and is listed on NASDAQ. The stock is currently priced at $3.05, with a market capitalization of $14.63M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.63 to $5.25. This page covers its latest market performance, valuation, price trends and company information.
$14.63M | |
$3.18 | |
$600.00 | |
$1.63 | |
$3.18 | |
115.03K | |
159.12K | |
-- | |
$5.25 | |
$1.63 | |
-- | |
-- |
HeartSciences Inc. (HSCS) is currently trading at $3.05 as of 2026-10-16 19:51:00, down 4.09% ($0.13) from the previous close of $3.18
During today's regular trading session, HSCS has traded between $1.63 and $600.00, with a trading volume of 115.03K shares. The current price is near the lower end of today's range.
Over the past seven days, HeartSciences Inc. (HSCS) moved from $3.49 to $3.05, representing a decline of 12.61% ($0.44).
The stock traded between $2.89 and $3.82 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 92.56 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 39.2%
HSCS is currently trading at $3.05, placing it 39.2% of the way from its 52-week low of $1.63 to its 52-week high of $5.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
| Industry | FINANCE SERVICES |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of HeartSciences Inc. (HSCS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.